| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 53 | 2024 | 10183 | 3.370 |
Why?
|
| Clonal Anergy | 24 | 2008 | 169 | 3.130 |
Why?
|
| Cord Blood Stem Cell Transplantation | 9 | 2019 | 314 | 2.900 |
Why?
|
| rap1 GTP-Binding Proteins | 10 | 2013 | 60 | 1.840 |
Why?
|
| Graft vs Host Disease | 15 | 2019 | 2958 | 1.370 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 12 | 2012 | 323 | 1.290 |
Why?
|
| Adaptor Proteins, Signal Transducing | 12 | 2021 | 2917 | 1.270 |
Why?
|
| Virus Activation | 3 | 2019 | 319 | 1.260 |
Why?
|
| Interleukin-7 | 7 | 2015 | 142 | 1.250 |
Why?
|
| Neoplasms | 16 | 2024 | 21696 | 1.240 |
Why?
|
| Tumor Microenvironment | 8 | 2023 | 3590 | 1.200 |
Why?
|
| Lymphocyte Activation | 37 | 2024 | 5524 | 1.200 |
Why?
|
| CD4-Positive T-Lymphocytes | 13 | 2015 | 4386 | 1.130 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 7 | 2018 | 985 | 1.120 |
Why?
|
| T-Lymphocytes, Regulatory | 9 | 2020 | 2988 | 1.100 |
Why?
|
| Fetal Blood | 6 | 2019 | 1318 | 1.090 |
Why?
|
| Immunotherapy | 11 | 2023 | 4446 | 1.050 |
Why?
|
| T-Lymphocyte Subsets | 8 | 2019 | 1837 | 0.940 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2022 | 1142 | 0.870 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2023 | 903 | 0.860 |
Why?
|
| Tumor Suppressor Proteins | 12 | 2009 | 2850 | 0.860 |
Why?
|
| Interleukin-17 | 3 | 2013 | 901 | 0.810 |
Why?
|
| Signal Transduction | 41 | 2022 | 23404 | 0.810 |
Why?
|
| Interleukin-2 | 21 | 2012 | 1904 | 0.770 |
Why?
|
| BK Virus | 2 | 2019 | 129 | 0.760 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2020 | 64 | 0.740 |
Why?
|
| Membrane Proteins | 14 | 2021 | 7882 | 0.740 |
Why?
|
| Integrins | 5 | 2021 | 846 | 0.730 |
Why?
|
| Myeloid Cells | 3 | 2022 | 810 | 0.720 |
Why?
|
| Polyomavirus Infections | 2 | 2019 | 200 | 0.690 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2020 | 234 | 0.670 |
Why?
|
| Thymus Gland | 3 | 2014 | 1267 | 0.660 |
Why?
|
| Jurkat Cells | 12 | 2020 | 743 | 0.660 |
Why?
|
| Tumor Virus Infections | 2 | 2019 | 454 | 0.660 |
Why?
|
| Peyer's Patches | 1 | 2018 | 121 | 0.650 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 10 | 2019 | 5445 | 0.640 |
Why?
|
| Cyclin-Dependent Kinase 2 | 4 | 2014 | 191 | 0.620 |
Why?
|
| Herpesvirus 6, Human | 1 | 2018 | 95 | 0.610 |
Why?
|
| Antigens, CD | 28 | 2019 | 4026 | 0.610 |
Why?
|
| Immune Tolerance | 12 | 2014 | 2259 | 0.610 |
Why?
|
| Killer Cells, Natural | 2 | 2024 | 2133 | 0.590 |
Why?
|
| Antigens, Differentiation | 14 | 2010 | 927 | 0.580 |
Why?
|
| Smad3 Protein | 4 | 2012 | 180 | 0.570 |
Why?
|
| cdc25 Phosphatases | 2 | 2012 | 62 | 0.540 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 4 | 2005 | 166 | 0.540 |
Why?
|
| Receptors, Antigen, T-Cell | 17 | 2016 | 2540 | 0.530 |
Why?
|
| Immunity | 2 | 2020 | 1014 | 0.530 |
Why?
|
| Immunologic Memory | 1 | 2022 | 1348 | 0.530 |
Why?
|
| Phosphorylation | 16 | 2020 | 8436 | 0.520 |
Why?
|
| Flow Cytometry | 6 | 2021 | 5974 | 0.520 |
Why?
|
| Immunoconjugates | 13 | 2002 | 901 | 0.520 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2022 | 4479 | 0.510 |
Why?
|
| Stem Cell Factor | 1 | 2015 | 219 | 0.500 |
Why?
|
| Colonic Neoplasms | 2 | 2020 | 2542 | 0.500 |
Why?
|
| Oxidation-Reduction | 2 | 2023 | 2184 | 0.500 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2016 | 282 | 0.500 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 3 | 2012 | 379 | 0.490 |
Why?
|
| S-Phase Kinase-Associated Proteins | 3 | 2012 | 90 | 0.490 |
Why?
|
| ras Proteins | 4 | 2012 | 1060 | 0.490 |
Why?
|
| Cell Adhesion | 8 | 2021 | 3144 | 0.480 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 598 | 0.480 |
Why?
|
| Forkhead Transcription Factors | 5 | 2023 | 1613 | 0.480 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 1889 | 0.480 |
Why?
|
| Cell Cycle | 12 | 2009 | 2967 | 0.470 |
Why?
|
| G1 Phase | 4 | 2012 | 415 | 0.470 |
Why?
|
| Tumor Escape | 1 | 2016 | 350 | 0.470 |
Why?
|
| Lipolysis | 1 | 2015 | 210 | 0.470 |
Why?
|
| Animals | 63 | 2023 | 168768 | 0.470 |
Why?
|
| B-Lymphocytes | 10 | 2018 | 4666 | 0.460 |
Why?
|
| Cell Differentiation | 11 | 2022 | 11486 | 0.460 |
Why?
|
| Cell Cycle Proteins | 10 | 2006 | 3464 | 0.460 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2018 | 789 | 0.440 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 65 | 0.440 |
Why?
|
| Casein Kinase II | 1 | 2013 | 128 | 0.440 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2012 | 56 | 0.430 |
Why?
|
| Autoimmunity | 3 | 2014 | 1350 | 0.420 |
Why?
|
| Viremia | 2 | 2019 | 736 | 0.420 |
Why?
|
| Cyclin-Dependent Kinases | 7 | 2006 | 671 | 0.420 |
Why?
|
| Immunophenotyping | 11 | 2021 | 1880 | 0.410 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2019 | 3390 | 0.400 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2009 | 2916 | 0.400 |
Why?
|
| Receptors, Interleukin-2 | 5 | 2005 | 573 | 0.390 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 2134 | 0.390 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2012 | 2504 | 0.390 |
Why?
|
| Phosphatidylinositol 3-Kinases | 7 | 2012 | 2938 | 0.390 |
Why?
|
| Glycolysis | 1 | 2015 | 829 | 0.380 |
Why?
|
| Humans | 134 | 2024 | 744366 | 0.380 |
Why?
|
| Transforming Growth Factor beta | 4 | 2010 | 2007 | 0.380 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 345 | 0.370 |
Why?
|
| Immunity, Innate | 2 | 2021 | 2962 | 0.370 |
Why?
|
| Carrier Proteins | 6 | 2009 | 5023 | 0.360 |
Why?
|
| Purines | 2 | 2014 | 594 | 0.360 |
Why?
|
| Melanoma | 3 | 2020 | 5511 | 0.360 |
Why?
|
| HLA-DR7 Antigen | 6 | 1996 | 27 | 0.350 |
Why?
|
| Phospholipase C gamma | 1 | 2009 | 128 | 0.350 |
Why?
|
| Mice | 38 | 2023 | 81201 | 0.340 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2016 | 8432 | 0.340 |
Why?
|
| Isoantigens | 6 | 2005 | 567 | 0.340 |
Why?
|
| Cells, Cultured | 20 | 2015 | 19233 | 0.340 |
Why?
|
| Receptors, OX40 | 1 | 2008 | 43 | 0.320 |
Why?
|
| Interleukin-1beta | 2 | 2012 | 972 | 0.320 |
Why?
|
| Neoplasm Proteins | 3 | 2015 | 3707 | 0.320 |
Why?
|
| Lymphocyte Depletion | 2 | 2008 | 608 | 0.320 |
Why?
|
| Clone Cells | 10 | 2010 | 1692 | 0.320 |
Why?
|
| Cytomegalovirus | 2 | 2010 | 733 | 0.320 |
Why?
|
| Cell Proliferation | 10 | 2014 | 10483 | 0.310 |
Why?
|
| Adoptive Transfer | 2 | 2010 | 844 | 0.310 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2005 | 4554 | 0.310 |
Why?
|
| Antibodies, Monoclonal | 8 | 2023 | 9274 | 0.300 |
Why?
|
| Hematologic Neoplasms | 2 | 2016 | 1832 | 0.300 |
Why?
|
| MAP Kinase Signaling System | 3 | 2012 | 1525 | 0.300 |
Why?
|
| Enzyme Activation | 6 | 2020 | 3702 | 0.290 |
Why?
|
| Fatty Acids | 1 | 2015 | 1809 | 0.290 |
Why?
|
| Glioma | 2 | 2022 | 3401 | 0.290 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 9 | 2008 | 1596 | 0.290 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1378 | 0.280 |
Why?
|
| Down-Regulation | 5 | 2004 | 3001 | 0.280 |
Why?
|
| Cell Adhesion Molecules | 3 | 2004 | 1602 | 0.270 |
Why?
|
| Transcription, Genetic | 10 | 2012 | 7721 | 0.260 |
Why?
|
| COS Cells | 5 | 2020 | 1161 | 0.260 |
Why?
|
| Th2 Cells | 3 | 2008 | 1061 | 0.260 |
Why?
|
| Growth Inhibitors | 1 | 2006 | 385 | 0.260 |
Why?
|
| Integrin alpha Chains | 1 | 2005 | 97 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 21833 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 3 | 2020 | 116 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinases | 7 | 2005 | 1284 | 0.250 |
Why?
|
| Cyclic AMP | 3 | 2007 | 1472 | 0.250 |
Why?
|
| Interleukin-10 | 2 | 2001 | 1200 | 0.250 |
Why?
|
| Phagocytosis | 3 | 2022 | 1539 | 0.250 |
Why?
|
| Cytoskeleton | 1 | 2009 | 1185 | 0.250 |
Why?
|
| Interphase | 1 | 2004 | 226 | 0.240 |
Why?
|
| Protein Multimerization | 2 | 2020 | 971 | 0.240 |
Why?
|
| Brain Neoplasms | 3 | 2023 | 8861 | 0.240 |
Why?
|
| Interferon-alpha | 5 | 1991 | 895 | 0.240 |
Why?
|
| Cytokines | 11 | 2019 | 7323 | 0.230 |
Why?
|
| Contractile Proteins | 1 | 2004 | 246 | 0.230 |
Why?
|
| Transplantation, Homologous | 5 | 2014 | 4777 | 0.230 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3646 | 0.230 |
Why?
|
| Cytomegalovirus Infections | 1 | 2010 | 820 | 0.220 |
Why?
|
| Granzymes | 3 | 2021 | 271 | 0.220 |
Why?
|
| Lung | 1 | 2021 | 9857 | 0.220 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2003 | 133 | 0.220 |
Why?
|
| Desensitization, Immunologic | 1 | 2008 | 483 | 0.220 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2022 | 122 | 0.220 |
Why?
|
| Apoptosis | 11 | 2019 | 9724 | 0.220 |
Why?
|
| DNA Methylation | 1 | 2016 | 4285 | 0.220 |
Why?
|
| Lymphocytes | 2 | 2010 | 2617 | 0.210 |
Why?
|
| Glioblastoma | 3 | 2023 | 3481 | 0.210 |
Why?
|
| Transfection | 10 | 2007 | 5895 | 0.210 |
Why?
|
| Dendritic Cells | 7 | 2023 | 2725 | 0.210 |
Why?
|
| Retinoblastoma Protein | 4 | 2012 | 705 | 0.210 |
Why?
|
| src Homology Domains | 2 | 2020 | 364 | 0.200 |
Why?
|
| Phosphoproteins | 4 | 2012 | 2441 | 0.200 |
Why?
|
| Mice, Transgenic | 7 | 2020 | 9735 | 0.200 |
Why?
|
| Phosphogluconate Dehydrogenase | 1 | 2021 | 22 | 0.200 |
Why?
|
| Receptors, Immunologic | 2 | 2019 | 1423 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2009 | 4424 | 0.190 |
Why?
|
| Inflammation | 1 | 2020 | 10637 | 0.190 |
Why?
|
| Allergens | 1 | 2008 | 1320 | 0.190 |
Why?
|
| Remission Induction | 8 | 2016 | 2385 | 0.180 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2001 | 651 | 0.180 |
Why?
|
| Cell Nucleus | 2 | 2007 | 2969 | 0.180 |
Why?
|
| Microfilament Proteins | 2 | 2004 | 1152 | 0.180 |
Why?
|
| Lymphocyte Culture Test, Mixed | 8 | 2007 | 518 | 0.180 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2023 | 604 | 0.170 |
Why?
|
| Brain Edema | 1 | 2023 | 617 | 0.170 |
Why?
|
| Membrane Glycoproteins | 13 | 2002 | 3771 | 0.170 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 2003 | 2455 | 0.170 |
Why?
|
| Macrophage Activation | 1 | 2002 | 560 | 0.170 |
Why?
|
| Foscarnet | 1 | 2018 | 38 | 0.160 |
Why?
|
| Reactive Oxygen Species | 2 | 2023 | 2076 | 0.160 |
Why?
|
| Hypersensitivity | 1 | 2008 | 1102 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 5 | 2013 | 3848 | 0.160 |
Why?
|
| Tyrosine | 2 | 2019 | 1462 | 0.160 |
Why?
|
| Cancer Vaccines | 3 | 2016 | 1023 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 2428 | 0.160 |
Why?
|
| Immunologic Factors | 2 | 2022 | 1580 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2000 | 1085 | 0.150 |
Why?
|
| Coculture Techniques | 3 | 2014 | 1341 | 0.150 |
Why?
|
| Ubiquitin | 2 | 2013 | 851 | 0.150 |
Why?
|
| Antigen-Presenting Cells | 5 | 2010 | 973 | 0.150 |
Why?
|
| Mice, Knockout | 7 | 2021 | 14561 | 0.150 |
Why?
|
| Chimerism | 1 | 2018 | 158 | 0.150 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2002 | 810 | 0.150 |
Why?
|
| Up-Regulation | 5 | 2012 | 4222 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2014 | 5534 | 0.150 |
Why?
|
| Interleukin-4 | 7 | 2008 | 1147 | 0.150 |
Why?
|
| Neoplastic Stem Cells | 4 | 2004 | 1376 | 0.150 |
Why?
|
| 3T3 Cells | 7 | 1998 | 1101 | 0.150 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2007 | 2943 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 4 | 2011 | 480 | 0.140 |
Why?
|
| Immunosuppressive Agents | 4 | 2018 | 4153 | 0.140 |
Why?
|
| Gene Expression Regulation | 8 | 2013 | 12073 | 0.140 |
Why?
|
| Disease-Free Survival | 4 | 2016 | 6896 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2019 | 1157 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 4 | 2011 | 489 | 0.140 |
Why?
|
| Hodgkin Disease | 8 | 2004 | 1415 | 0.140 |
Why?
|
| Cell Line | 9 | 2012 | 16000 | 0.140 |
Why?
|
| Angiopoietin-1 | 1 | 2016 | 114 | 0.140 |
Why?
|
| Thrombomodulin | 1 | 2016 | 102 | 0.140 |
Why?
|
| Protein Kinases | 3 | 2008 | 1640 | 0.140 |
Why?
|
| Germinal Center | 1 | 2018 | 377 | 0.130 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 13693 | 0.130 |
Why?
|
| Cyclins | 4 | 2002 | 603 | 0.130 |
Why?
|
| Gangliosides | 1 | 1996 | 137 | 0.130 |
Why?
|
| Mucin-1 | 2 | 2010 | 543 | 0.130 |
Why?
|
| Angiopoietin-2 | 1 | 2016 | 172 | 0.130 |
Why?
|
| Antioxidants | 1 | 2023 | 1659 | 0.130 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2004 | 1520 | 0.130 |
Why?
|
| Immunity, Mucosal | 1 | 2018 | 490 | 0.130 |
Why?
|
| Talin | 3 | 2013 | 44 | 0.130 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 5692 | 0.130 |
Why?
|
| Cell Line, Tumor | 6 | 2023 | 16690 | 0.130 |
Why?
|
| Guanine | 5 | 1996 | 274 | 0.130 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 3 | 2004 | 318 | 0.130 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2015 | 86 | 0.130 |
Why?
|
| DNA, Viral | 2 | 2019 | 2227 | 0.130 |
Why?
|
| Recurrence | 3 | 2016 | 8340 | 0.130 |
Why?
|
| Lymphoma, Non-Hodgkin | 4 | 1999 | 1381 | 0.120 |
Why?
|
| Macrophages | 4 | 2023 | 5660 | 0.120 |
Why?
|
| Antigen Presentation | 4 | 2010 | 1284 | 0.120 |
Why?
|
| Actins | 4 | 2007 | 2121 | 0.120 |
Why?
|
| Treatment Outcome | 10 | 2020 | 63107 | 0.120 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2008 | 641 | 0.120 |
Why?
|
| HLA-B7 Antigen | 1 | 1993 | 48 | 0.120 |
Why?
|
| Bone Marrow Transplantation | 2 | 1999 | 2765 | 0.120 |
Why?
|
| Female | 34 | 2020 | 380193 | 0.120 |
Why?
|
| Pseudopodia | 2 | 2004 | 172 | 0.120 |
Why?
|
| Proteins | 3 | 2007 | 6100 | 0.120 |
Why?
|
| RNA Splicing | 1 | 2018 | 908 | 0.120 |
Why?
|
| Lymphopoiesis | 1 | 2014 | 135 | 0.120 |
Why?
|
| Interferon-gamma | 7 | 2014 | 3207 | 0.120 |
Why?
|
| Recombinant Proteins | 9 | 2007 | 6621 | 0.120 |
Why?
|
| Transcriptional Activation | 2 | 2012 | 1783 | 0.110 |
Why?
|
| Cell Separation | 2 | 2010 | 1751 | 0.110 |
Why?
|
| Ligands | 6 | 2021 | 3282 | 0.110 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2005 | 1475 | 0.110 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 970 | 0.110 |
Why?
|
| Enzyme Stability | 1 | 2013 | 210 | 0.110 |
Why?
|
| Phosphatidylinositol Phosphates | 2 | 2012 | 209 | 0.110 |
Why?
|
| Vaccination | 4 | 2016 | 3279 | 0.110 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2008 | 548 | 0.110 |
Why?
|
| Adult | 28 | 2019 | 214052 | 0.110 |
Why?
|
| Tissue Donors | 3 | 2018 | 2241 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 634 | 0.100 |
Why?
|
| Male | 31 | 2020 | 350115 | 0.100 |
Why?
|
| Glucose | 1 | 2004 | 4398 | 0.100 |
Why?
|
| Perforin | 1 | 2012 | 168 | 0.100 |
Why?
|
| Molecular Structure | 1 | 2016 | 1899 | 0.100 |
Why?
|
| RNA, Messenger | 9 | 2013 | 13035 | 0.100 |
Why?
|
| WT1 Proteins | 2 | 2014 | 178 | 0.100 |
Why?
|
| Growth Substances | 1 | 1994 | 784 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 1213 | 0.100 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2012 | 140 | 0.100 |
Why?
|
| Protein Binding | 2 | 2020 | 9384 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 17446 | 0.100 |
Why?
|
| Procarbazine | 4 | 2004 | 181 | 0.100 |
Why?
|
| Middle Aged | 26 | 2019 | 213390 | 0.100 |
Why?
|
| Phosphotyrosine | 2 | 2005 | 457 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4208 | 0.090 |
Why?
|
| Cell Survival | 7 | 2011 | 5882 | 0.090 |
Why?
|
| Antibodies, Viral | 2 | 2019 | 3177 | 0.090 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2004 | 906 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2004 | 647 | 0.090 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2010 | 148 | 0.090 |
Why?
|
| Dacarbazine | 5 | 2004 | 566 | 0.090 |
Why?
|
| Guanosine Triphosphate | 2 | 2003 | 321 | 0.090 |
Why?
|
| Transplantation Conditioning | 3 | 2019 | 1599 | 0.090 |
Why?
|
| Gene Expression | 5 | 2012 | 7798 | 0.090 |
Why?
|
| Lymphoma, Follicular | 2 | 2008 | 435 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2006 | 3773 | 0.090 |
Why?
|
| Transplantation, Heterologous | 3 | 2021 | 2383 | 0.090 |
Why?
|
| Aged | 24 | 2019 | 163288 | 0.090 |
Why?
|
| Genes, bcl-2 | 2 | 2001 | 122 | 0.090 |
Why?
|
| Histocompatibility | 2 | 2002 | 330 | 0.090 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2009 | 127 | 0.090 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2001 | 433 | 0.090 |
Why?
|
| Viral Load | 1 | 2018 | 3300 | 0.090 |
Why?
|
| Young Adult | 4 | 2019 | 56429 | 0.080 |
Why?
|
| Sirolimus | 2 | 2010 | 1565 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 705 | 0.080 |
Why?
|
| Kinetics | 2 | 2015 | 6476 | 0.080 |
Why?
|
| Cell Movement | 2 | 2011 | 5218 | 0.080 |
Why?
|
| Models, Animal | 2 | 2009 | 2173 | 0.080 |
Why?
|
| Cell Membrane | 2 | 2012 | 3749 | 0.080 |
Why?
|
| Blood Cells | 2 | 2008 | 309 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3486 | 0.080 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 2 | 2000 | 67 | 0.080 |
Why?
|
| Spleen | 2 | 2010 | 2362 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1997 | 1862 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2001 | 1434 | 0.080 |
Why?
|
| Amino Acid Sequence | 8 | 2004 | 13814 | 0.080 |
Why?
|
| Cell Division | 5 | 2004 | 4569 | 0.080 |
Why?
|
| Molecular Sequence Data | 9 | 2004 | 18111 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 697 | 0.070 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 2 | 2007 | 102 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2006 | 1159 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2004 | 829 | 0.070 |
Why?
|
| Protein Transport | 2 | 2009 | 1988 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4751 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2004 | 2839 | 0.070 |
Why?
|
| Disease Progression | 2 | 2022 | 13286 | 0.070 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2006 | 113 | 0.070 |
Why?
|
| Genes, cdc | 1 | 2006 | 116 | 0.070 |
Why?
|
| Cell Count | 1 | 2010 | 1856 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 7 | 2008 | 6313 | 0.070 |
Why?
|
| Vaccines, DNA | 1 | 2008 | 305 | 0.070 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2007 | 215 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 2 | 2000 | 563 | 0.070 |
Why?
|
| Interleukins | 2 | 2004 | 791 | 0.070 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1998 | 222 | 0.070 |
Why?
|
| Glutathione Transferase | 2 | 2004 | 595 | 0.070 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2006 | 177 | 0.070 |
Why?
|
| Cullin Proteins | 1 | 2006 | 181 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 595 | 0.070 |
Why?
|
| Epitopes | 2 | 2007 | 2571 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 3511 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 6 | 2006 | 6386 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2725 | 0.060 |
Why?
|
| CHO Cells | 6 | 2008 | 1409 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2006 | 464 | 0.060 |
Why?
|
| Profilins | 1 | 2004 | 66 | 0.060 |
Why?
|
| Receptor, Notch1 | 1 | 2008 | 502 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2008 | 572 | 0.060 |
Why?
|
| Vidarabine | 2 | 2019 | 345 | 0.060 |
Why?
|
| Lymph Nodes | 4 | 2010 | 3476 | 0.060 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 407 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2004 | 1683 | 0.060 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2004 | 193 | 0.060 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2005 | 199 | 0.060 |
Why?
|
| Melphalan | 2 | 2019 | 431 | 0.060 |
Why?
|
| Cricetinae | 6 | 2008 | 2475 | 0.060 |
Why?
|
| Interferon Type I | 1 | 1988 | 542 | 0.060 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2004 | 104 | 0.060 |
Why?
|
| DNA Primers | 2 | 2007 | 2891 | 0.060 |
Why?
|
| RNA Interference | 1 | 2012 | 2890 | 0.060 |
Why?
|
| Receptors, Interleukin | 1 | 2004 | 245 | 0.060 |
Why?
|
| Cambodia | 2 | 2002 | 191 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2005 | 2926 | 0.060 |
Why?
|
| Prognosis | 7 | 2015 | 29060 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3873 | 0.060 |
Why?
|
| Binding Sites | 3 | 2006 | 6111 | 0.060 |
Why?
|
| Tuberculin Test | 2 | 2002 | 214 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2006 | 3130 | 0.050 |
Why?
|
| Receptors, Transferrin | 1 | 2004 | 296 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12244 | 0.050 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2004 | 440 | 0.050 |
Why?
|
| Proline | 1 | 2004 | 458 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2006 | 5867 | 0.050 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2002 | 40 | 0.050 |
Why?
|
| Luciferases | 1 | 2004 | 733 | 0.050 |
Why?
|
| Peptides | 2 | 2008 | 4410 | 0.050 |
Why?
|
| Blood Proteins | 2 | 2012 | 1124 | 0.050 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2002 | 67 | 0.050 |
Why?
|
| S Phase | 2 | 2002 | 423 | 0.050 |
Why?
|
| Fibronectins | 1 | 2006 | 726 | 0.050 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2002 | 94 | 0.050 |
Why?
|
| Models, Biological | 5 | 2013 | 9584 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 937 | 0.050 |
Why?
|
| Depression, Chemical | 1 | 2001 | 191 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2006 | 627 | 0.050 |
Why?
|
| Granulocytes | 1 | 2023 | 548 | 0.050 |
Why?
|
| 6-Aminonicotinamide | 1 | 2021 | 8 | 0.050 |
Why?
|
| Smad2 Protein | 1 | 2001 | 156 | 0.050 |
Why?
|
| Flavonoids | 1 | 2004 | 443 | 0.050 |
Why?
|
| Hypersensitivity, Delayed | 2 | 2000 | 484 | 0.050 |
Why?
|
| Transplantation Tolerance | 1 | 2006 | 617 | 0.050 |
Why?
|
| Enzyme Inhibitors | 2 | 2004 | 3799 | 0.050 |
Why?
|
| Transplantation, Autologous | 2 | 2013 | 2124 | 0.050 |
Why?
|
| Bone Marrow | 4 | 1997 | 2948 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2004 | 589 | 0.050 |
Why?
|
| Smad4 Protein | 1 | 2001 | 163 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2004 | 1137 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 3524 | 0.050 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2021 | 124 | 0.050 |
Why?
|
| bcl-Associated Death Protein | 2 | 1998 | 107 | 0.050 |
Why?
|
| Cyclosporine | 2 | 1994 | 788 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2004 | 1794 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 494 | 0.050 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2023 | 475 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2010 | 9647 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2009 | 2499 | 0.050 |
Why?
|
| CD40 Ligand | 1 | 2002 | 526 | 0.050 |
Why?
|
| DNA Fragmentation | 2 | 1997 | 242 | 0.050 |
Why?
|
| Blood Platelets | 2 | 2008 | 2509 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2002 | 335 | 0.050 |
Why?
|
| Antigens, Neoplasm | 3 | 2016 | 1988 | 0.050 |
Why?
|
| Janus Kinase 3 | 2 | 2003 | 78 | 0.050 |
Why?
|
| Cyclin D2 | 1 | 2000 | 101 | 0.050 |
Why?
|
| Liposomes | 1 | 2023 | 759 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2002 | 430 | 0.040 |
Why?
|
| Blood Group Incompatibility | 1 | 2001 | 146 | 0.040 |
Why?
|
| Th1 Cells | 2 | 2002 | 1057 | 0.040 |
Why?
|
| Mitochondria | 2 | 2021 | 3514 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2003 | 508 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2004 | 1677 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 2 | 1998 | 295 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 1997 | 1821 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2006 | 821 | 0.040 |
Why?
|
| Neoplasm Staging | 9 | 2004 | 11031 | 0.040 |
Why?
|
| bcl-X Protein | 2 | 1998 | 411 | 0.040 |
Why?
|
| Listeria monocytogenes | 1 | 2021 | 250 | 0.040 |
Why?
|
| DNA Repair | 3 | 1996 | 2046 | 0.040 |
Why?
|
| Whole-Body Irradiation | 1 | 2019 | 449 | 0.040 |
Why?
|
| Antigens, Surface | 2 | 2001 | 1663 | 0.040 |
Why?
|
| Acute Disease | 1 | 2009 | 7147 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2021 | 596 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2000 | 384 | 0.040 |
Why?
|
| rap GTP-Binding Proteins | 1 | 1997 | 28 | 0.040 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 1997 | 34 | 0.040 |
Why?
|
| Tacrolimus | 2 | 2010 | 743 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2002 | 1802 | 0.040 |
Why?
|
| Lymphotoxin-alpha | 2 | 1995 | 98 | 0.040 |
Why?
|
| Preleukemia | 1 | 1997 | 35 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2008 | 4561 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 1997 | 119 | 0.040 |
Why?
|
| Receptor Aggregation | 2 | 1993 | 80 | 0.040 |
Why?
|
| Lymphatic Diseases | 2 | 2001 | 323 | 0.040 |
Why?
|
| Leukemia, B-Cell | 1 | 1997 | 86 | 0.040 |
Why?
|
| Fas Ligand Protein | 1 | 1997 | 216 | 0.040 |
Why?
|
| Base Sequence | 2 | 2007 | 12797 | 0.040 |
Why?
|
| Survival Rate | 2 | 2009 | 12788 | 0.040 |
Why?
|
| Caspase 1 | 1 | 1997 | 224 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 1097 | 0.040 |
Why?
|
| Vidarabine Phosphate | 1 | 1996 | 11 | 0.040 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1996 | 91 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2000 | 539 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 18034 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2004 | 4010 | 0.040 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 1996 | 140 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 686 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2002 | 1470 | 0.030 |
Why?
|
| Semaphorins | 1 | 1996 | 101 | 0.030 |
Why?
|
| DNA | 4 | 2003 | 7294 | 0.030 |
Why?
|
| Vitamin D | 1 | 2010 | 3224 | 0.030 |
Why?
|
| Rats | 6 | 2023 | 24252 | 0.030 |
Why?
|
| Dimerization | 1 | 1997 | 895 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2006 | 12207 | 0.030 |
Why?
|
| Cricetulus | 2 | 2008 | 818 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2008 | 7914 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 2000 | 1000 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 2013 | 5181 | 0.030 |
Why?
|
| Cloning, Molecular | 3 | 1998 | 4320 | 0.030 |
Why?
|
| Burkitt Lymphoma | 1 | 1997 | 327 | 0.030 |
Why?
|
| Paraproteins | 1 | 1994 | 39 | 0.030 |
Why?
|
| Mitogens | 2 | 2010 | 232 | 0.030 |
Why?
|
| Leukocytes | 3 | 1994 | 2045 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 2088 | 0.030 |
Why?
|
| Bleomycin | 3 | 2004 | 512 | 0.030 |
Why?
|
| Receptors, Cytokine | 1 | 1995 | 262 | 0.030 |
Why?
|
| Monocytes | 1 | 2023 | 2596 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 2012 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2013 | 11525 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 1997 | 1263 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1993 | 143 | 0.030 |
Why?
|
| Vinblastine | 3 | 2004 | 502 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2003 | 3424 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1997 | 581 | 0.030 |
Why?
|
| Calcineurin | 1 | 1994 | 226 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2006 | 4217 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2000 | 1335 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2006 | 4397 | 0.030 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 4 | 1996 | 85 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1994 | 250 | 0.030 |
Why?
|
| Epirubicin | 2 | 2004 | 80 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1994 | 338 | 0.030 |
Why?
|
| Transplantation Immunology | 1 | 1994 | 546 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2011 | 2716 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2013 | 365 | 0.030 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2001 | 1052 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1996 | 640 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 2013 | 290 | 0.030 |
Why?
|
| Electroporation | 1 | 1993 | 251 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2016 | 973 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 2182 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2000 | 1988 | 0.030 |
Why?
|
| Leukemia, Hairy Cell | 1 | 1991 | 82 | 0.020 |
Why?
|
| Vincristine | 3 | 2004 | 1039 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2002 | 1832 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2004 | 15078 | 0.020 |
Why?
|
| Immune System | 1 | 2016 | 806 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2011 | 95 | 0.020 |
Why?
|
| Reference Values | 2 | 1997 | 4982 | 0.020 |
Why?
|
| Brain | 1 | 2017 | 26388 | 0.020 |
Why?
|
| Thrombocytosis | 1 | 1991 | 81 | 0.020 |
Why?
|
| Mechlorethamine | 2 | 2004 | 136 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 1993 | 936 | 0.020 |
Why?
|
| Methyltransferases | 4 | 1996 | 367 | 0.020 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2010 | 71 | 0.020 |
Why?
|
| Splenectomy | 1 | 1991 | 395 | 0.020 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2011 | 241 | 0.020 |
Why?
|
| Thrombocythemia, Essential | 1 | 1991 | 105 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2013 | 795 | 0.020 |
Why?
|
| Placenta | 1 | 2018 | 1699 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2010 | 297 | 0.020 |
Why?
|
| Tuberculosis | 1 | 2002 | 1912 | 0.020 |
Why?
|
| Time Factors | 3 | 2004 | 40075 | 0.020 |
Why?
|
| Antilymphocyte Serum | 1 | 2010 | 492 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1993 | 1117 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1656 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2012 | 2012 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 1991 | 1588 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2011 | 498 | 0.020 |
Why?
|
| Receptor, PAR-1 | 1 | 2008 | 113 | 0.020 |
Why?
|
| Leukemia | 2 | 2010 | 1510 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1993 | 1758 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1994 | 931 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 2086 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2013 | 1607 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2010 | 645 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 1994 | 738 | 0.020 |
Why?
|
| Phytohemagglutinins | 2 | 1996 | 170 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2010 | 1369 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1994 | 2036 | 0.020 |
Why?
|
| Species Specificity | 3 | 1996 | 2478 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2008 | 381 | 0.020 |
Why?
|
| Fluorescence | 1 | 2008 | 751 | 0.020 |
Why?
|
| Radiotherapy Dosage | 2 | 2004 | 2879 | 0.020 |
Why?
|
| Prednisone | 2 | 2004 | 1574 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2007 | 477 | 0.020 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2004 | 88 | 0.020 |
Why?
|
| Carcinoma | 1 | 1996 | 2375 | 0.020 |
Why?
|
| Interleukin-9 | 1 | 2004 | 63 | 0.020 |
Why?
|
| Antibody Specificity | 2 | 1998 | 1095 | 0.020 |
Why?
|
| Immunoglobulins | 2 | 2000 | 881 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 1539 | 0.020 |
Why?
|
| Vaccinia | 1 | 2004 | 76 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 2008 | 545 | 0.010 |
Why?
|
| Focal Adhesions | 1 | 2004 | 121 | 0.010 |
Why?
|
| Interleukin-15 | 1 | 2004 | 184 | 0.010 |
Why?
|
| Autocrine Communication | 1 | 2004 | 171 | 0.010 |
Why?
|
| Immunoglobulin M | 2 | 2001 | 1537 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1991 | 4933 | 0.010 |
Why?
|
| Combined Modality Therapy | 3 | 2004 | 8642 | 0.010 |
Why?
|
| Random Allocation | 1 | 1988 | 2428 | 0.010 |
Why?
|
| Isoantibodies | 1 | 2007 | 679 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 3616 | 0.010 |
Why?
|
| Tuberculin | 1 | 2002 | 66 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1997 | 5856 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9445 | 0.010 |
Why?
|
| Doxorubicin | 2 | 2004 | 2234 | 0.010 |
Why?
|
| Chlorambucil | 1 | 2001 | 43 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2004 | 625 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 2001 | 85 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2008 | 956 | 0.010 |
Why?
|
| Mumps | 1 | 2002 | 64 | 0.010 |
Why?
|
| Lentivirus | 1 | 2004 | 503 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2006 | 1227 | 0.010 |
Why?
|
| Karyotyping | 1 | 2003 | 1243 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39052 | 0.010 |
Why?
|
| Blood Viscosity | 1 | 2001 | 124 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2008 | 1275 | 0.010 |
Why?
|
| Splenomegaly | 1 | 2001 | 190 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2007 | 10252 | 0.010 |
Why?
|
| Cardiac Output, Low | 1 | 2001 | 195 | 0.010 |
Why?
|
| Fibroblasts | 2 | 2004 | 4162 | 0.010 |
Why?
|
| Neutrophils | 1 | 2013 | 3721 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4851 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1998 | 19905 | 0.010 |
Why?
|
| Skin Tests | 1 | 2002 | 613 | 0.010 |
Why?
|
| Translocation, Genetic | 2 | 1998 | 1420 | 0.010 |
Why?
|
| Graft Survival | 1 | 2010 | 3737 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1730 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 1157 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2003 | 1879 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 2110 | 0.010 |
Why?
|
| Rabbits | 2 | 1996 | 4894 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 29786 | 0.010 |
Why?
|
| Embryonal Carcinoma Stem Cells | 1 | 1998 | 20 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1998 | 349 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 1998 | 253 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2001 | 692 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1998 | 245 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1998 | 299 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1999 | 793 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 29144 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 2513 | 0.010 |
Why?
|
| Adolescent | 6 | 2004 | 85779 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2219 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 1998 | 279 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 1999 | 613 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 1996 | 244 | 0.010 |
Why?
|
| Neoplasms, Second Primary | 1 | 2004 | 1062 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6366 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2004 | 3505 | 0.010 |
Why?
|
| Oligoclonal Bands | 1 | 1994 | 16 | 0.010 |
Why?
|
| Receptors, IgE | 1 | 1996 | 389 | 0.010 |
Why?
|
| DNA Damage | 2 | 1996 | 2432 | 0.010 |
Why?
|
| Multigene Family | 1 | 1998 | 1102 | 0.010 |
Why?
|
| Keratinocytes | 1 | 1998 | 799 | 0.010 |
Why?
|
| Fatigue | 1 | 2001 | 1531 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 1995 | 311 | 0.010 |
Why?
|
| Phenotype | 2 | 2003 | 16367 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1993 | 427 | 0.010 |
Why?
|
| Melanoma, Experimental | 1 | 1996 | 561 | 0.010 |
Why?
|
| Bone Marrow Examination | 1 | 1993 | 157 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1995 | 841 | 0.010 |
Why?
|
| Risk | 1 | 2004 | 9688 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 6234 | 0.010 |
Why?
|
| Rural Population | 1 | 2002 | 2207 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1996 | 2008 | 0.010 |
Why?
|
| Biopsy | 2 | 1994 | 6755 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2004 | 57776 | 0.010 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1994 | 337 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1994 | 995 | 0.010 |
Why?
|
| Immunoassay | 1 | 1994 | 752 | 0.010 |
Why?
|
| Lymphoma | 1 | 1999 | 1877 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1993 | 2050 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2001 | 3461 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1991 | 2186 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 14723 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1996 | 20824 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1993 | 10943 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1993 | 2256 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1994 | 1402 | 0.010 |
Why?
|
| Epithelium | 1 | 1993 | 1679 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1991 | 1420 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 5709 | 0.000 |
Why?
|
| Tissue and Organ Procurement | 1 | 1996 | 896 | 0.000 |
Why?
|
| Platelet Count | 1 | 1991 | 780 | 0.000 |
Why?
|
| Physical Examination | 1 | 1993 | 1237 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 15535 | 0.000 |
Why?
|
| Incidence | 1 | 2004 | 20952 | 0.000 |
Why?
|
| Neurons | 1 | 2004 | 9340 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1996 | 8300 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 6171 | 0.000 |
Why?
|
| Child | 2 | 2004 | 77709 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1994 | 11366 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2002 | 40559 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1993 | 12961 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1991 | 8319 | 0.000 |
Why?
|
| Infant | 1 | 1999 | 35134 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1999 | 41005 | 0.000 |
Why?
|
| Liver | 1 | 1990 | 7475 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2001 | 77460 | 0.000 |
Why?
|